Ivermectin induces chicken BCRP/ABCG2 expression and function: Involvement of CXR signaling pathway and mRNA stabilization.

Ivermectin is a macrocyclic lactone antiparasitic drug widely used in human and veterinary medicine. Previous studies indicated that ivermectin could interact with P-glycoprotein, being a good inducer and substrate; however, it is unknown whether ivermectin affects BCRP of chicken. In this study, we found that ivermectin distinctly affected the expression of BCRP in a time- and concentration-dependent up-regulatory way in chicken primary hepatocytes. Subsequent series of experiments showed that the BCRP induction is related with the increase of CXR expression and, promoting CXR translocations to the nucleus and enhancing the stability of Abcg2 mRNA at the post-transcriptional level by ivermectin. Furthermore, we observed that ivermectin also enhanced the stability of Abcg2 mRNA at the post-transcriptional level by Act-D chase assay. We got the similar results by in vivo test that ivermectin-induced BCRP and CXR expression in pharmacologically important tissues, and decreased the apparent permeability coefficient of florfenicol (substrate of chicken BCRP). In conclusion, the results indicated that ivermectin could induce chicken BCRP expression and function through the transcriptional CXR signaling pathway and post-transcriptional mRNA stabilization.

[1]  D. Francés,et al.  Induction of P-glycoprotein expression and activity by prolactin in female rat liver. , 2021, Life sciences.

[2]  Slobodan Petar Rendic Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects , 2021, Archives of Toxicology.

[3]  R. Martin,et al.  Ivermectin: An Anthelmintic, an Insecticide, and Much More. , 2020, Trends in parasitology.

[4]  Ping Li,et al.  Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes , 2020, International journal of molecular sciences.

[5]  P. Kroon,et al.  Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters , 2020, Nutrients.

[6]  L. Aleksunes,et al.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species , 2020, Expert opinion on drug metabolism & toxicology.

[7]  Liping Wang,et al.  Identification of Functional Transcriptional Binding Sites within Chicken Abcg2 Gene Promoter and Screening Its Regulators , 2020, Genes.

[8]  V. Bin,et al.  Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  P. Hunt,et al.  The impacts of Ascaridia galli on performance, health, and immune responses of laying hens: new insights into an old problem , 2019, Poultry science.

[10]  Yuqi Wu,et al.  MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells. , 2019, Molecular medicine reports.

[11]  M. Zloh,et al.  Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies , 2019, International journal of molecular sciences.

[12]  J. Beijnen,et al.  ABC transporters Mdr1a/1b, Bcrp1, Mrp2 and Mrp3 determine the sensitivity to PhIP/DSS-induced colon carcinogenesis and inflammation , 2019, Archives of Toxicology.

[13]  Yigang Wang,et al.  Thiocoraline mediates drug resistance in MCF-7 cells via PI3K/Akt/BCRP signaling pathway , 2019, Cytotechnology.

[14]  A. Lifschitz,et al.  Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications. , 2019, Current medicinal chemistry.

[15]  M. Zloh,et al.  Relevance of Breast Cancer Resistance Protein to Pharmacokinetics of Florfenicol in Chickens: A Perspective from In Vivo and In Vitro Studies , 2018, International journal of molecular sciences.

[16]  Qingcheng Mao,et al.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus , 2018, Expert opinion on drug metabolism & toxicology.

[17]  G. Dyckhoff,et al.  Human papilloma virus (HPV) 18 proteins E6 and E7 up-regulate ABC transporters in oropharyngeal carcinoma. Involvement of the nonsense-mediated decay (NMD) pathway. , 2018, Cancer letters.

[18]  M. Butler,et al.  Rare FMR1 gene mutations causing fragile X syndrome: A review , 2018, American journal of medical genetics. Part A.

[19]  D. Hira,et al.  BCRP/ABCG2 and high‐alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications , 2018, Biochemical pharmacology.

[20]  R. Laing,et al.  Ivermectin – Old Drug, New Tricks? , 2017, Trends in parasitology.

[21]  V. Korolchuk,et al.  Selenomethionine Alleviates AFB1-Induced Damage in Primary Chicken Hepatocytes by Inhibiting CYP450 1A5 Expression via Upregulated SelW Expression. , 2017, Journal of agricultural and food chemistry.

[22]  Qingcheng Mao,et al.  Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts , 2017, Molecular Pharmacology.

[23]  M. Daniele,et al.  Residue depletion of ivermectin in broiler poultry , 2017, Food Additives and Contaminants Part A-chemistry Analysis Control Exposure & Risk Assessment.

[24]  G. Merino,et al.  Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep. , 2013, Veterinary journal.

[25]  A. Lifschitz,et al.  In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheep. , 2012, Veterinary journal.

[26]  M. Alvinerie,et al.  Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. , 2012, Biochemical pharmacology.

[27]  M. Mori,et al.  Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease. , 2009, Current drug targets.

[28]  M. Negishi,et al.  New insights on the xenobiotic-sensing nuclear receptors in liver diseases--CAR and PXR--. , 2008, Current drug metabolism.

[29]  A. V. van Herwaarden,et al.  The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin , 2005, Molecular Pharmacology.

[30]  J. Stegeman,et al.  Transcriptional Activation of Cytochrome P450 CYP2C45 by Drugs Is Mediated by the Chicken Xenobiotic Receptor (CXR) Interacting with a Phenobarbital Response Enhancer Unit* , 2002, The Journal of Biological Chemistry.

[31]  P. Souček,et al.  Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama). , 2001, Chemico-biological interactions.

[32]  C. Handschin,et al.  CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Handschin,et al.  A Conserved Nuclear Receptor Consensus Sequence (DR-4) Mediates Transcriptional Activation of the Chicken CYP2H1 Gene by Phenobarbital in a Hepatoma Cell Line* , 2000, The Journal of Biological Chemistry.